Blog | Coffee Break Conversations

Artificial intelligence (AI) is becoming increasingly important in our personal and professional lives. However, there appears to be some confusion regarding terms such as "artificial intelligence", "machine learning (ML)", "data science (DS)", "office automation (OA)", and "robotic process automation" (RPA), which should not be used interchangeably.

How can we distinguish between a consumer-grade and a medical device? In this article, we will explore the differences between consumer-grade and medical devices, when should a device be considered a medical device, and where the lines between them blur.

Deciding to invest time in reviewing your company’s mission and vision is not always easy. Taking a moment to reflect means a race against time: time to plan, time to implement, time to listen.

By using technology and other solutions to overcome the dependency of the brick-and-mortar research site, Decentralised Clinical Trials can improve patient retention, increase participant diversity, and improve data collection, among other benefits. Let’s take a closer look at the challenges posed by DCTs and how to overcome them.

The publication of the MDR/IVR was a milestone in the Medical Devices revolution, yet, the state of play of the medical devices sector is not yet up to it. Manufacturers are now facing the actual capacity of Notified Bodies (NB) to address all incoming requests to issue MDR/IVDR certificates.

Read this interview to discover one of the most complex professional challenges for Medical Affairs: the need to rapidly produce scientific (non-clinical) data that can be used for corporate communication.

We will explore the characteristics of modern pharmacovigilance during the clinical research stage, the documents needed for a drug’s market approval,
and how post-market surveillance is conducted.